Director/PDMR Shareholding

RNS Number : 1214C

Genedrive PLC

05 February 2020

 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the near patient molecular diagnostics company, announces that Dr Ian Gilham, Non-Executive Chairman, acquired 125,000 ordinary shares of 1.5p each ("Ordinary Shares") today at 8p per share and Tom Lindsay, Non-Executive Director, acquired 125,000 Ordinary Shares today at 8p per share.

Gino Miele, R&D Director and a PDMR, acquired 27,798 Ordinary Shares in the Company at a price of 11.56p per share yesterday and acquired 20,921 Ordinary Shares at 9.5p per share today.

Following these purchases, Dr Ian Gilham is interested in 490.674 Ordinary Shares, 1.4% of the issued share capital of the Company, Tom Lindsay is interested in 190,217 Ordinary Shares, 0.5% of the issued share capital of the Company and Gino Miele is interested in 56,719 Ordinary Shares, 0.2% of the issued share capital of the Company.

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	1.   Ian Gilham 2.   Tom Lindsay
2.	Reason for the notification
a.	Position/status	1.   Non-Executive Chairman 2.   Non-Executive Director
a.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	genedrive plc
b.	LEI	213800ZYODIRZ87Y4K14
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 1.5 pence each GB00B1VKB244
b.	Nature of the transaction	Purchase
c.	Price(s) and volume(s)	Price(s) Volume(s) 1.   8p 1.   125,000 2.   8p 3.   125,000
d.	Aggregated information ·      Aggregated volume ·      Price	N/A
e.	Date of the transaction	2020-02-05
f.	Place of the transaction	London Stock Exchange, AIM

1.	Details of the person discharging managerial responsibilities / person closely associated
b.	Name	Gino Miele
2.	Reason for the notification
c.	Position/status	R&D Director
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
g.	Name	genedrive plc
h.	LEI	213800ZYODIRZ87Y4K14
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
i.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 1.5 pence each GB00B1VKB244
j.	Nature of the transaction	Purchase
k.	Price(s) and volume(s)	Price(s) Volume(s) 11.56p 27,798
l.	Aggregated information ·      Aggregated volume ·      Price	N/A
m.	Date of the transaction	2020-02-04
n.	Place of the transaction	London Stock Exchange, AIM
5.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 1.5 pence each GB00B1VKB244
b.	Nature of the transaction	Purchase
c.	Price(s) and volume(s)	Price(s) Volume(s) 9.5p 20,921
d.	Aggregated information ·      Aggregated volume ·      Price	N/A
e.	Date of the transaction	2020-02-05
f.	Place of the transaction	London Stock Exchange, AIM

For further details please contact:

genedrive plc	[phone]
David Budd: CEO / Matthew Fowler: CFO
Peel Hunt LLP (Nominated Adviser and Joint Broker)	[phone]
James Steel / Oliver Jackson
Stanford Capital Partners Limited (Joint Broker)	[phone]
Patrick Claridge / John Howes
Walbrook PR Ltd (Media Relations & Investor Relations)	[phone] or [e-mail]
Paul McManus / Anna Dunphy	[phone] / [phone]

 

END

 

 

DSHEAXASEDEEEFA